WallStSmart

POMDOCTOR LIMITED American Depositary Shares (POM)vsRidgetech, Inc. (RDGT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

POMDOCTOR LIMITED American Depositary Shares generates 233% more annual revenue ($399.92M vs $119.94M). RDGT leads profitability with a 10.3% profit margin vs -53.2%. RDGT earns a higher WallStSmart Score of 37/100 (F).

POM

Avoid

28

out of 100

Grade: F

Growth: 6.7Profit: 2.5Value: 5.0Quality: 4.5
Piotroski: 4/9

RDGT

Hold

37

out of 100

Grade: F

Growth: 2.7Profit: 5.0Value: 5.0Quality: 6.5
Piotroski: 4/9Altman Z: 1.41

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

POM1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
17.2%8/10

17.2% revenue growth

RDGT3 strengths · Avg: 9.7/10
Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Return on EquityProfitability
30.2%10/10

Every $100 of equity generates 30 in profit

Debt/EquityHealth
0.169/10

Conservative balance sheet, low leverage

Areas to Watch

POM4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$14.51M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Free Cash FlowQuality
$-149.49M2/10

Negative free cash flow — burning cash

RDGT4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$1.27M3/10

Smaller company, higher risk/reward

Revenue GrowthGrowth
-11.7%2/10

Revenue declined 11.7%

Altman Z-ScoreHealth
1.412/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : POM

The strongest argument for POM centers on Revenue Growth. Revenue growth of 17.2% demonstrates continued momentum.

Bull Case : RDGT

The strongest argument for RDGT centers on Price/Book, Return on Equity, Debt/Equity.

Bear Case : POM

The primary concerns for POM are EPS Growth, Market Cap, Return on Equity.

Bear Case : RDGT

The primary concerns for RDGT are EPS Growth, Market Cap, Revenue Growth.

Key Dynamics to Monitor

POM profiles as a growth stock while RDGT is a declining play — different risk/reward profiles.

POM is growing revenue faster at 17.2% — sustainability is the question.

RDGT generates stronger free cash flow (5M), providing more financial flexibility.

Monitor PHARMACEUTICAL RETAILERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

RDGT scores higher overall (37/100 vs 28/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

POMDOCTOR LIMITED American Depositary Shares

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

Pomdoctor Limited, offers an online B2C portal to sell pharmaceutical products. The company is headquartered in Guangzhou, China.

Visit Website →

Ridgetech, Inc.

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

China Jo-Jo Drugstores, Inc. is a retailer and wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company is headquartered in Hangzhou, the People's Republic of China.

Visit Website →

Want to dig deeper into these stocks?